Blue7 is a Singapore based impact investor.
We directly support passionate entrepreneurs with bold and effective solutions that address underserved needs in livelihood resilience, community development and environmental protection. We also invest in global impact funds as well as ESG scored listed equities.
Blue7 deploys a variety of financial instruments ranging from debt to equity. Working with partners in Asia and beyond, our portfolio operates to create long term value for society and the environment.
Philosophy
At Blue7, the 7 core values of partnership, innovation, success, faith, humility, resilience and dignity guide us. We believe in the role of capital to redefine business goals to maximise social, environmental as well as economic returns.
Focus
COMMUNITIES
We believe in building more resilient communities by investing in innovative solutions to deliver access to affordable education, quality healthcare and economic progress for all their residents. We favour businesses with strong inclusiveness in their leadership and workforce policies.
ENVIRONMENT
We are humbled by our collective poor stewardship of our environment and feel the urgent need to support businesses to succeed in the sustainable production and responsible conservation of energy, clean water, air quality, food and other resources with environmental impact.
LIVELIHOOD
We see the need to bridge the current huge wealth inequalities and the importance of partnering with enterprises to provide better livelihood opportunities and restore dignity to the disadvantaged poor.
Team
Juanita FU
Co-Founder
Juanita's vision is that Blue7 invest in viable solutions that tackle societal and environmental challenges. It is her belief that there can be sustainable models to address some of these problems through deploying capital in creative ways.
She is also a General Partner in a life science venture capital fund. Juanita has a BS from Columbia University and an MD from the University of Southern California.
MA Hui Hsing
Co-Founder
Hui Hsing's mission is that Blue7 help businesses redirect responsibilities towards multi-stakeholders and ESG excellence. She has worked globally in healthcare investment, corporate finance, and general management. Her volunteer experience is in child welfare and education in Southeast Asia.
Hui Hsing holds a MS in Biotechnology from the Johns Hopkins University, USA; a MBA from Manchester Business School, UK; and, a BAcc from the National University of Singapore.
KUA Qiu Quan
Associate
Qiu Quan believes strongly in the role of capital markets in international development. He previously worked with the finance team of a Geneva-based foundation, and with a Singapore based social impact consultancy firm.
He holds a Master's degree in Development Studies, from IHEID in Geneva, Switzerland, with a research focus on impact investing and sustainable finance, and a BSS (Hons) in Economics from the National University of Singapore.
Selected Portfolio
Aavishkaar creates sustainable change in rural India through venture capital financing and management support to socially-conscious, environmentally friendly, commercially viable ventures that currently have limited or no access to established financial institutions.
Find out more
Garden Impact Investments is a Singapore-based investment holding company that focuses on making investments in commercially sustainable, scalable businesses that impact communities mired in poverty, with a focus on the Southeast Asia region.
reach52 provides accessible and affordable healthcare services to communities where healthcare access is limited.
-
Bespoke listed ESG thematic portfolios invested through third-party asset managers
-
Credit Suisse Rockefeller Ocean Engagement Fund
Aqua-Spark is a Netherlands-based global investment fund focused on sustainable aquaculture businesses.
Leapfrog invests in Africa and Asia, with a focus on financial services and healthcare.
Sanergy builds “Fresh Life” toilets and franchises them to local entrepreneurs. Waste is collected at a centralized facility and converted into valuable end-products such as organic fertilizer and insect-based animal feed.
At One Ventures invests in early-stage companies that are using disruptive deep tech to upend the unit economics of established industries while dramatically reducing their planetary footprint.
Greenhope produces plastic alternatives Oxium (oxo-biodegradable additive) and Ecoplas (cassava based plastic).
Smarter Health is a digital technology business on a mission to make healthcare more transparent, efficient and accessible to all in Southeast Asia.
Global listed ESG securities
CHEN Jingxuan
Intern
Jingxuan has a keen interest in the areas where economics, finance and public policy intersect, hoping to effect positive changes on the community. Prior to Blue7, she interned with a Singapore-based sovereign wealth fund and global asset management firms, giving her exposure to a wide variety of sectors and asset classes.
She is on track to completing her Bachelor's of Engineering (Chemical) and Bachelor's of Social Sciences (Economics) degrees from the National University of Singapore.
Network
Blue7 is a member of the following networks:
News
Company feature: reach52
Read more